Ra Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference
March 01 2017 - 07:00AM
Business Wire
Ra Pharmaceuticals, Inc., (NASDAQ:RARX), a clinical stage
biopharmaceutical company focusing on the development of
next-generation therapeutics for the treatment of
complement-mediated diseases, today announced that Doug Treco, PhD,
President and Chief Executive Officer, will present at the Cowen
and Company 37th Annual Health Care Conference on Tuesday, March 7,
2017 at 11:20 a.m. E.T. The conference is being held at the Boston
Marriott Copley Place.
The presentation will be webcast live and can be accessed by
visiting the investor relations section of the Company’s website,
www.rapharma.com. A replay of the presentation will also be
available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the
complement cascade. For more information, please visit:
www.rapharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170301005376/en/
Ra Pharmaceuticals, Inc.Investors:Jennifer Robinson,
617.674.9873jrobinson@rapharma.comorMedia:Argot PartnersEliza
Schleifstein, 917.763.8106eliza@argotpartners.com
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Mar 2023 to Mar 2024